Table 2.

Robust Poisson regression models estimating the association between perceiving oneself at high risk for severe COVID-19 (vs. not) and taking a COVID-19 oral antiviral within 5 days of suspected infection

Covariates included in models*	Prevalence ratio for oral antiviral uptake (95%CIs)
Crude (perceived risk only)	2.11 (1.55—2.88)
Adjusted for
Age, gender, race/ethnicity	1.94 (1.41—2.67)
Education, household income, current employment status, geographic region, lives in an MSA, children < 18 in household	2.00 (1.45—2.76)
Vaccination status, number and timing of SARS-CoV-2 infection	2.00 (1.47—2.72)
At least one underlying condition	2.08 (1.51—2.85)
Fully adjusted model	1.72 (1.23—2.40)

*Covariates included: age group (18–34, 35–49, 50–64, and ≥ 65 years), self-reported gender (male or female), race/ethnicity (Black, non-Hispanic; Hispanic; White, non-Hispanic; and other race or multiracial, non-Hispanic), education (high school graduate or less, some college, or Bachelor’s degree or above), household income (< $50,000, $50,000–$99,9999, ≥ $100,000), employment status (full-time, part-time, or not employed), geographic region (Northeast, Midwest, South, West), residence in a metropolitan statistical area (MSA) (yes or no), any children under 18 in the household (yes or no), total doses of COVID vaccine received (none, 1–2 doses, ≥ 3 doses), multiple SARS-CoV-2 infections (yes or no), timing of most recent SARS-CoV-2 infection (within the last month, 1–6 months ago, 6–12 months ago, > 12 months ago), and having at least one underlying condition (yes or no). Underlying conditions included being overweight or obese, pregnant or recently pregnant, or a current smoker; or having diabetes, chronic obstructive pulmonary disease (COPD) or lung disease, cystic fibrosis, tuberculosis, asthma, liver disease, heart disease, high blood pressure, cerebrovascular disease, chronic kidney disease, depression, anxiety, another mental health condition, dementia, or an immunocompromising condition (i.e., a cancer, recent organ transplant, human immunodeficiency virus [HIV], or taking immunosuppressive medications)